the EMA had its decision prior to Affy being delisted, shouldnt shareholders have gotten that information today?
why do you think they changed to OTC before the meeting...
Now that they are OTC they don't have to tell you s.
no, i asked about this and the asnwer i got was that takeda most likely withdrew the application because the company is not aware of an approval in europe.
EMA would have revealed that information before hand. All the w/d applications are listed in their Web site.
Peganesatide was listed as taken up for review. It is reviewed and we don't know the outcome.
Sentiment: Strong Buy
but I checked EMA's website, Omontys is not on the withdrawal list.
so no EU in the picture right now....
"they don't care about us" Micheal Jackson